glp-1 receptor agonists PDB-101: Molecule of the Month: GLP-1 receptor agonists and next-generation

Brain endothelial cells regulate glucagon-like peptide 1 entry into the brain via a receptor-mediated process

Long-term administration of (Pro 3 )GIP to obese mice on an HFD was found to reduce body weight by about 8% compared to controls, without affecting food intake, and decrease casual blood glucose levels during the course of treatment and attenuated insulin levels during an oral glucose tolerance test [118]

Sie gelten in diesem Fall als sogenannte Lifestyle-Medikamente

Liu W, Liu J, Huang Z, Cui Z, Li L, Liu W, et al

Journal of Pharmacy Technology, 38 (4), 239246.

New research from 23and ME sheds a light on why GLP-1 weight-loss drugs work differently across patients, with two studies suggesting that genetic variation and cardiovascular mechanisms independent of weight loss may both play significant roles in determining individual outcomes